Akumin, Inc. (AKU)

NASDAQ: AKU · IEX Real-Time Price · USD
-0.017 (-1.94%)
At close: May 20, 2022 4:00 PM
0.000 (0.012%)
After-hours:May 20, 2022 4:00 PM EDT

Company Description

Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology.

The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, and other diagnostic or interventional radiology procedures through a network of approximately 200 owned and/or operated imaging locations.

It provides outpatient radiology, and oncology services and solutions to approximately 1,000 hospitals and health systems across 46 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida.

Akumin, Inc.
Akumin Logo
CountryUnited States
IndustryDiagnostics & Research
SectorHealth Care

Contact Details

8300 West Sunrise Boulevard
Plantation, FL 33322
United States
Phone954 577 6000

Stock Details

Ticker SymbolAKU
Fiscal YearJanuary - December
Reporting CurrencyUS Dollars
CIK Code1776197

Key Executives

Riadh Zine-El-AbidineChairman and Chief Executive Officer
Matthew CameronChief Legal Officer and Corporate Secretary
Rohit NavaniExecutive Vice President and Chief Transformation Officer
William Edward LarkinChief Financial Officer
Paul NelisChief Information Officer
Darren SpeedChief Compliance Officer
Tracy WieseChief Strategy and Marketing Officer
Holly HusoEnterprise Sales Officer
Lori Marker SPHRVice President of Human Resources
Laurie R. MillerChief Human Resources Officer

Latest SEC Filings

May 10, 2022S-4/ARegistration of securities, business combinations
May 10, 202210-QQuarterly report [Sections 13 or 15(d)]
May 10, 20228-KCurrent report
Apr 25, 20228-KCurrent report
Apr 21, 2022425Prospectuses and communications, business combinations
Apr 21, 20228-KCurrent report
Apr 21, 2022S-4Registration of securities, business combinations
Apr 14, 2022424B3Prospectus [Rule 424(b)(3)]
Apr 14, 2022EFFECTNotice of Effectiveness
Apr 11, 202210-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]
View All SEC Filings